Correction made after online publication 4 April 2016. Table 1 was updated to correct the Interval of *n* ~dir~ to 6 and *n* ~slice~ to 7.

INTRODUCTION {#mrm26195-sec-0005}
============

Diffusion‐weighted imaging (DWI) probes tissue properties on the microscopic level [1](#mrm26195-bib-0001){ref-type="ref"}. Physiologically important parameters such as the density and diameter of axons can be estimated by modeling the effect of the cellular environment on diffusion‐weighted data [2](#mrm26195-bib-0002){ref-type="ref"}, [3](#mrm26195-bib-0003){ref-type="ref"}, [4](#mrm26195-bib-0004){ref-type="ref"}, [5](#mrm26195-bib-0005){ref-type="ref"}. Such modeling generally assumes that water is confined within intra‐ and extracellular compartments, separated by cell membranes. However, water exchange takes place between the compartments, either directly through the lipid bilayer or facilitated through so‐called aquaporins (AQP) [6](#mrm26195-bib-0006){ref-type="ref"}, [7](#mrm26195-bib-0007){ref-type="ref"}. The exchange rate is proportional to the cell membrane permeability to water [8](#mrm26195-bib-0008){ref-type="ref"}, [9](#mrm26195-bib-0009){ref-type="ref"}, which is important for cell volume regulation [10](#mrm26195-bib-0010){ref-type="ref"} and for conditions involving edema such as tumors, infection, and stroke [11](#mrm26195-bib-0011){ref-type="ref"}, [12](#mrm26195-bib-0012){ref-type="ref"}. In aggressive tumors, AQP upregulation has been demonstrated [13](#mrm26195-bib-0013){ref-type="ref"}, [14](#mrm26195-bib-0014){ref-type="ref"}, [15](#mrm26195-bib-0015){ref-type="ref"}. Quantification of exchange rates by MRI may yield a biomarker that is sensitive to alterations of cell membrane permeability, and offer improved diagnostics and more adequate treatment.

Conventional DWI is based on the single‐diffusion encoding (SDE) experiment, and the data acquired are typically analyzed by methods such as diffusion tensor imaging (DTI) or diffusion kurtosis imaging (DKI), which do not account for effects of exchange. It is possible to estimate the exchange rate of water between compartments using SDE by acquiring data using multiple diffusion times and applying a modified Kärger model [16](#mrm26195-bib-0016){ref-type="ref"}, [17](#mrm26195-bib-0017){ref-type="ref"}, [18](#mrm26195-bib-0018){ref-type="ref"}. However, this approach has the limitation that the effects from exchange and restricted diffusion are entangled. With increased diffusion time, effects from exchange increase the attenuation for high *b*‐values, whereas effects from restriction reduce it [18](#mrm26195-bib-0018){ref-type="ref"}. For higher specificity to exchange, a double‐diffusion encoding (DDE) sequence can be employed [9](#mrm26195-bib-0009){ref-type="ref"}, [19](#mrm26195-bib-0019){ref-type="ref"}. Filter exchange imaging (FEXI) is a DDE‐based method implemented for clinical use that yields the apparent exchange rate (AXR) [20](#mrm26195-bib-0020){ref-type="ref"}. The advantages of estimating AXR rather than using the Kärger model were discussed previously [20](#mrm26195-bib-0020){ref-type="ref"}.

The AXR is sensitive to changes in membrane permeability [9](#mrm26195-bib-0009){ref-type="ref"}, [20](#mrm26195-bib-0020){ref-type="ref"}, and has been measured in the healthy human brain and a meningioma brain tumor [21](#mrm26195-bib-0021){ref-type="ref"}. In fixed monkey brain, a tensor‐based AXR analysis has been explored [22](#mrm26195-bib-0022){ref-type="ref"}. Preliminary data showed that the AXR is sensitive to altered gene expression of the urea transporter [23](#mrm26195-bib-0023){ref-type="ref"}. The FEXI method has also been applied to investigate breast tumor cells [24](#mrm26195-bib-0024){ref-type="ref"}. The FEXI method has great promise, but its reproducibility in a clinical setting has not yet been studied. In this study, we aimed to optimize and analyze the ability of FEXI to infer differences in the AXR in the brain between two populations in clinical studies. We took three steps to meet this aim. First, we optimized a FEXI protocol for minimal AXR variance caused by measurement noise. Second, we investigated the AXR variance in the normal brain by performing a test‐retest study on healthy volunteers, using the optimized protocol. Third, we obtained FEXI data from patients with meningiomas and astrocytomas to demonstrate that the AXR is sensitive to their microstructural differences [25](#mrm26195-bib-0025){ref-type="ref"}.

THEORY {#mrm26195-sec-0006}
======

Filter Exchange Imaging {#mrm26195-sec-0007}
-----------------------

The FEXI pulse sequence is illustrated in Figure [1](#mrm26195-fig-0001){ref-type="fig"}. It is based on a stimulated‐echo DDE sequence with two pulsed gradient spin‐echo (PGSE) blocks separated by a mixing time (*t* ~m~) and followed by an echo‐planar imaging (EPI) block. The diffusion weighting factor (*b*) of the PGSE blocks is given by *b* = (γ*g*δ)^2^ *t* ~d~, in which γ is the nuclear gyromagnetic ratio and *t* ~d~ is the effective diffusion time (*t* ~d~ = Δ -- δ/3) of the gradient pairs with amplitude *g*, duration δ, and separation between the leading edges Δ, and correspondingly for the *b*‐value of the first block (*b* ~f~).

![Illustration of the FEXI pulse sequence. FEXI employs a stimulated echo DDE sequence. The two diffusion‐encoding blocks, the "filter" and the "detection" block, have gradient strengths *g*, diffusion weightings *b* ~f~ and *b*, and gradient timing parameter pairs (Δ~f~, δ~f~) and (Δ, δ), respectively. The magnetization is stored longitudinally during the mixing time (*t* ~m~) by the second 90° pulse, and then refocused by a third 90° pulse. Spoiler gradients dephase the magnetization excited by the extra 90° pulses. After the detection block, the signal is acquired by echo‐planar imaging (EPI, with readout time τ~EPI~).](MRM-77-1104-g001){#mrm26195-fig-0001}

To derive the FEXI model [20](#mrm26195-bib-0020){ref-type="ref"}, we assume that water exists in two compartments with approximately Gaussian diffusion and equal longitudinal and transversal relaxation rates, but different apparent diffusivities, denoted as "slow" (*D* ~s~) and "fast" (*D* ~f~), respectively. Water molecules in the slow and fast compartments contribute with equilibrium fractions of the MR signal ( $f_{s}^{\text{eq}}$ and $f_{f}^{\text{eq}}$), where $f_{s}^{\text{eq}}$ +  $f_{f}^{\text{eq}}$ = 1. In the presence of diffusion‐encoding gradients, the signal attenuation in each compartment is determined by its apparent diffusion coefficient (ADC). In FEXI, the diffusion weighting of the first PGSE block (the "filter block") will therefore preferentially attenuate, or "filter out," the signal from the fast compartment, which results in apparent signal fractions that are perturbed from equilibrium ( $f_{s}^{\prime}$ \>  $f_{s}^{\text{eq}}$ and $f_{f}^{\prime}$ \<  $f_{f}^{\text{eq}}$). During the mixing time, exchange takes place between the compartments, which at *t* ~m~ will have restored $f_{f}^{\prime}$ toward $f_{f}^{\text{eq}}$ according to $$f_{f}^{\prime}\left( t_{m} \right) = f_{f}^{\text{eq}} - \left\lbrack {f_{f}^{\text{eq}} - f_{f}^{\prime}\left( 0 \right)} \right\rbrack\exp\left( {- t_{m}\left\lbrack {k_{\text{sf}} + k_{\text{fs}}} \right\rbrack} \right),$$where *k* ~sf~ and *k* ~fs~ are the forward and reverse exchange rates between the slow and the fast compartment, and $f_{f}^{\prime}$(0) is the fast fraction immediately after the filter [9](#mrm26195-bib-0009){ref-type="ref"}. Due to mass balance, *k* ~sf~ and *k* ~fs~ are related to the fractions according to *f* ~s~ *k* ~sf~ = *f* ~f~ *k* ~fs~. The durations of the diffusion‐encoding blocks are assumed to be short enough for significant exchange to take place only during *t* ~m~ [9](#mrm26195-bib-0009){ref-type="ref"}. The diffusion weighting of the second PGSE block (the "detection block") is used to estimate the ADC, which depends on the fractions, and thus *t* ~m~, according to $$\text{ADC}\prime\left( t_{m} \right) = D_{s}\left\lbrack {1 - f_{f}^{\prime}\left( t_{m} \right)} \right\rbrack + D_{f}f_{f}^{\prime}\left( t_{m} \right).$$

Rather than using the Kärger model to obtain *D* ~s~, *D* ~f~, $f_{s}^{\text{eq}}$, $f_{f}^{\text{eq}}$, and the exchange rate *k* = *k* ~sf~ + *k* ~fs~ [9](#mrm26195-bib-0009){ref-type="ref"}, FEXI measures the response to *t* ~m~ in the initial, approximately monoexponential, decay of the signal. This decay is proportional to ADC\'(*t* ~m~), which is given by $$\text{ADC}\prime\left( t_{m} \right) = \text{ADC}\left\lbrack {1 - \sigma\exp\left( {- \text{AXR}t_{m}} \right)} \right\rbrack,$$where ADC is the apparent diffusion coefficient at equilibrium, σ = 1 -- ADC\'(0)/ADC is the filter efficiency, and AXR is the apparent exchange rate. In a two‐compartment system, AXR = *k*. In a multicompartment system, the AXR approximates the "mean exchange" in a similar way to how the ADC approximates the "mean diffusivity" [20](#mrm26195-bib-0020){ref-type="ref"}. The MR signal at *t* ~m~ is given by $$S\left( {b,t_{m}} \right) = S_{0}\left( t_{m} \right)\exp\left( {- b_{f}\text{ADC}} \right)\exp\left( {- b\text{ADC}}\left\lbrack {1 - \sigma\,\text{exp}\left( {- \text{AXR}t_{m}} \right)} \right\rbrack) \right.,$$where *S* ~0~(*t* ~m~) is the relaxation‐weighted signal without diffusion encoding [21](#mrm26195-bib-0021){ref-type="ref"}. The minimal sampling requirement to fit Eq. [(4)](#mrm26195-disp-0004){ref-type="disp-formula"} and estimate ADC, σ, and AXR is a combination of two different *b* with two different *t* ~m~. Additionally, 'unfiltered' data acquired with *b* ~f~ = 0 must be obtained for some number of *t* ~m~ to estimate the equilibrium ADC.

Statistical Power and Parameter Variance {#mrm26195-sec-0008}
----------------------------------------

We describe two concepts related to the analysis of the test‐retest data: analysis of statistical power, and partitioning variance contribution between intersubject differences within the population and measurement noise.

The power of a statistical test (*π*) that compares a parameter between two groups is the probability of the test to find an effect with significance (*α*) in the presence of a true difference. It depends on the effect size (such as a difference in means, Δ*μ*), the variance of parameter observations (*V*), and the group sizes (*n*, assuming they are equal). In the analysis of statistical power, any of these quantities (*α, π*, Δ*μ, V*, and *n*) can be calculated for a given type of test by fixing the values of the others [26](#mrm26195-bib-0026){ref-type="ref"}. This is useful in study design to ensure that group sizes are sufficiently large to assess an effect of known (or hypothesized) size.

In a population, the variance of parameter observations depends on both the intersubject variance (*V* ~I~) about the population mean (*μ*), and on the variance introduced by measurement noise (*V* ~M~). In a two‐level random effects model for an observation *Y* ~ij~ on subject *i* ∊ \[1...I\], in the repeated measurement *j* ∊ \[1...J\], this is expressed as $$Y_{ij} = \mu + \varepsilon_{i} + \varepsilon_{j},$$where *ε* ~i~ and *ε* ~j~ are the subject and measurement level errors, respectively [27](#mrm26195-bib-0027){ref-type="ref"}. The total variance is *V* = Var(*Y* ~ij~) = Var(*ε* ~i~) + Var(*ε* ~j~) = *V* ~I~ + *V* ~M~, assuming Cov(*ε* ~i~, *ε* ~j~) = 0. Provided data from at least two measurements (J \> 1), both *V* ~I~ and *V* ~M~ can be estimated. The relative variance contribution from measurement noise may then be estimated as *RV* ~M~ = *V* ~M~/(*V* ~I~ + *V* ~M~) = *V* ~M~/*V* [28](#mrm26195-bib-0028){ref-type="ref"}. It is a measure of the degree to which statistical power can be increased, and the required group sizes minimized, through experimental improvements such as protocol optimization.

METHODS {#mrm26195-sec-0009}
=======

Protocol Optimization {#mrm26195-sec-0010}
---------------------

We aimed to optimize a FEXI protocol for minimal variance in AXR caused by measurement noise (*V* ~M~). To reach this aim, we followed the concepts introduced by Alexander [29](#mrm26195-bib-0029){ref-type="ref"}, and minimized an objective function based on the Cramér‐Rao lower bound (CRLB) of the AXR. For estimates of a given model parameter in an unbiased model, the CRLB is a lower bound for *V* ~M~ [30](#mrm26195-bib-0030){ref-type="ref"}, [31](#mrm26195-bib-0031){ref-type="ref"}. It is expressed analytically based on the signal model (Eq. [(4)](#mrm26195-disp-0004){ref-type="disp-formula"} for FEXI), a noise model, and the experimental protocol. In the following, we describe two aspects of our approach: the FEXI protocol and the CRLB‐based protocol optimization.

### The FEXI protocol {#mrm26195-sec-0011}

With "protocol" we refer to the set of values for experimental parameters used during acquisition, such as the filter strength (*b* ~f~), the detection *b*‐value (*b*), and the mixing time (*t* ~m~). In our implementation, the acquisition loop obtains all detection *b*‐values and diffusion‐encoding directions for all mixing times, in which at least one mixing time is unfiltered (*b* ~f~ = 0). In the optimization, we simplified the protocol by considering only two different *b* and *t* ~m~. This approach is unlike that of the previously presented protocol, which used a range of *t* ~m~ [21](#mrm26195-bib-0021){ref-type="ref"}. We also fixed the values of the short *t* ~m~ ( $t_{m}^{\min}$ = 16 ms) and the low *b* (*b* ^min^ = 40 s/mm^2^), to maximize the signal‐to‐noise ratio (SNR) while allowing the spoiling of unwanted echoes. The unfiltered acquisitions always used the shortest *t* ~m~ to maximize the SNR.

The parameters left to the optimization were *b* ~f~, the high *b* (*b* ^max^), the long *t* ~m~ ( $t_{m}^{\max}$), the number of repetitions at the low and high *b* (\#*b* ^min^ and \#*b* ^max^), the number of repetitions at the short and long *t* ~m~ (\# $t_{m}^{\min}$ and \# $t_{m}^{\max}$), and the number of unfiltered mixing time repetitions (\# $b_{f}^{0}$). In addition, the maximal gradient amplitude (*g*) and the EPI readout time (*τ* ~EPI~) were kept free, yielding a total of 10 optimization parameters. The effective number was nine, however, due to the following relation: T^aq^/TR = *n* ~dir~(\#*b* ^min^ + \#*b* ^max^)(\# $t_{m}^{\min}$ + \# $t_{m}^{\max}$ + \# $b_{f}^{0}$), where T^aq^ is the acquisition time, *n* ~dir~ is the number of diffusion‐encoding directions, and TR is the repetition time. The full set of optimization parameters is presented in Table [1](#mrm26195-tbl-0001){ref-type="table-wrap"}, with allowed intervals. The upper limits for *b* and *b* ~*f*~ were set to 1300 s/mm^2^ to comply with the FEXI method of observing the initial decay of the signal‐to‐*b* curve. The upper limit for *g* (80 mT/m) reflects the constraints of the testing system. Other constraints were T^aq^ ≤ 15 min, *n* ~slice~ = 7, and *n* ~dir~ = 6.

###### 

Optimization Parameters of the FEXI Protocol[a](#mrm26195-note-0001){ref-type="fn"}

  Parameter             Interval   Optimum
  --------------------- ---------- ---------
  *b* ~f~ (s/mm^2^)     200−1300   830
  *b* ^max^ (s/mm^2^)   200−1300   1300
  $t_{m}^{\max}$ (ms)   200−800    442
  *\#b* ^min^           1−10       3
  *\#b* ^max^           1−10       6
  \# $t_{m}^{\min}$     1−10       2
  \# $t_{m}^{\max}$     1−10       2
  \# $b_{f}^{0}$        1−10       1
  *g* (mT/m)            40−80      80
  τ~EPI~ (ms)           30−100     63
  T^aq^ (s)             ≤900       780
  *n* ~dir~             6          
  *n* ~slice~           7          

The FEXI optimization parameters, together with some constraint parameters (T^aq^, *n* ~dir~, *n* ~slice~), are presented with allowed intervals and found optima. The optimized protocol reduced the CV of the AXR by approximately 40%, compared with the previously presented protocol [21](#mrm26195-bib-0021){ref-type="ref"}, corresponding to a more than 60% reduction in T^aq^. Main differences include using only two different *t* ~m~ and a higher *b* ^max^. The most important hardware limitation was the maximal gradient amplitude (*g*).

**Note**: *b* ~f~, filter strength; *b* ^max^, high detection *b*‐value; $t_{m}^{\max}$, long mixing time; \#*b* ^min/max^, number of repetitions at *b* ^min/max^; \# $t_{m}^{\text{min}/\text{max}}$, number of repetitions at $t_{m}^{\text{min}/\text{max}}$; \# $b_{f}^{0}$, number of mixing time repetitions in which *b* ~f~ = 0; *g*, maximal gradient amplitude; *τ* ~EPI~, EPI readout time; T^aq^, acquisition time; *n* ~dir~, number of diffusion‐encoding directions; *n* ~slice~, number of slices.

### CRLB‐Based Optimization {#mrm26195-sec-0012}

To optimize the protocol, we constructed an objective function based on the coefficient of variation (CV) of the AXR (CV =  $V_{M}^{1/2}$/AXR), and used the CRLB of the AXR to approximate *V* ~M~. The CRLB is obtained from the Fisher information matrix (*F*), which, assuming a Gaussian noise distribution, has the elements $$F_{ij} = \sigma_{n}^{- 2}\sum\limits_{k = 1}^{K}\frac{\partial S_{k}}{\partial m_{i}}\frac{\partial S_{k}}{\partial m_{j}},$$corresponding to the model parameters *m* ~i~ and m~j~. Here, σ~n~ is the noise standard deviation and *S* ~k~ is the predicted signal for the *k*th set of protocol parameters (Eq. [(4)](#mrm26195-disp-0004){ref-type="disp-formula"}). The CRLB of model parameter *m* ~i~ is the *i*th diagonal element of the inverse *F*: CRLB~i~ = (*F* ^‐1^)~ii~ [29](#mrm26195-bib-0029){ref-type="ref"}.

The assumption of Gaussian noise in Eq. [(6)](#mrm26195-disp-0006){ref-type="disp-formula"} is valid for SNR values above ∼2 [32](#mrm26195-bib-0032){ref-type="ref"}. To avoid protocols yielding an SNR near this limit, we introduced a penalty factor based on the minimum SNR of all measurement points (SNR~min~), according to *f* ~P~ = 1 + ( $f_{P}^{\text{max}}$− 1) · (1 + exp\[α (SNR~min~ − SNR~tol~)\])^−1^, where α = 6, $f_{P}^{\text{max}}$ = 10 and SNR~tol~ = 3.

The full objective function was obtained by averaging the SNR‐penalized CV estimate over priors calculated from the two‐compartment exchange model [33](#mrm26195-bib-0033){ref-type="ref"} (*D* ~s~, *D* ~f~, *f* ~f~, and the exchange time τ~i~ = 1/*k* ~sf~) according to $$OF = \frac{1}{IJKL}\sum\limits_{i~ = 1}^{I}\sum\limits_{j~ = 1}^{J}\sum\limits_{k~ = 1}^{K}\sum\limits_{l~ = 1}^{L}\left\lbrack {\frac{CRLB{(D_{s}{}^{i},~D_{f}{}^{j},~f_{f}{}^{k},\tau_{i}{}^{l})}^{1/2}}{AXR(f_{f}{}^{k},\tau_{i}{}^{l})}f_{P}(SNR_{ijkl}{}^{min})} \right\rbrack.$$

The interval for the exchange time was postulated, τ~i~ ∊ \[1.0, 4.0\] s, whereas the other priors were based on previous studies of white matter [34](#mrm26195-bib-0034){ref-type="ref"}, [35](#mrm26195-bib-0035){ref-type="ref"}, [36](#mrm26195-bib-0036){ref-type="ref"}: *D* ~s~ ∊ \[0.1, 0.3\] µm^2^/ms, *D* ~f~ ∊ \[0.9, 1.3\] µm^2^/ms, and *f* ~f~ ∊ \[0.4, 0.7\].

In the calculations, the SNR of the nondiffusion‐encoded signal (*S* ~0~ in Eq. [(4)](#mrm26195-disp-0004){ref-type="disp-formula"}) was set to a reference value (SNR~ref~ = 40) and rescaled based on departures from corresponding reference values of the echo times of the filter and detection blocks (TE~fref~ = 39 ms and TE~ref~ = 53 ms), the repetition time (TR~ref~ = 2500 ms), and the EPI readout time (*τ* ~EPIref~ = 63 ms) [21](#mrm26195-bib-0021){ref-type="ref"}. The scaling was given by $$\text{SNR} = \text{SNR}_{\text{ref}} \cdot F_{\text{TEfTE}} \cdot F_{\text{TR}} \cdot F_{\tau\text{EPI}},$$where $$F_{\text{TEfTE}} = \exp\left( {\left\lbrack {\left( {\text{TE}_{\text{fref}} - \text{TE}_{f}} \right) + \left( {\text{TE}_{\text{ref}} - \text{TE}_{}} \right)} \right\rbrack/T_{2}} \right),$$ $$F_{\text{TR}} = \left\lbrack {1 - \exp\left( {- \text{TR}/T_{1}} \right)} \right\rbrack/\left\lbrack {1 - \exp\left( {- \text{TR}_{\text{ref}}/T_{1}} \right)} \right\rbrack,\text{and}$$ $$F_{\tau\text{EPI}} = \left( {\tau\text{EPI}/{\tau\text{EPI}}_{\text{ref}}} \right)^{1/2}.$$

The relaxation time constants were given fixed values, *T* ~1~/*T* ~2~ = 700/50 ms/ms, which were both low compared with values reported in white matter [35](#mrm26195-bib-0035){ref-type="ref"}, [37](#mrm26195-bib-0037){ref-type="ref"}, [38](#mrm26195-bib-0038){ref-type="ref"}, but chosen to err on the safe side of low SNR (FEXI loses SNR for short *T* ~1~ due to relaxation during *t* ~m~). Calculation of the echo times were based on *g* and *τ* ~EPI~, according to TE~f~ = 2\[*δ* ~f~(*g,b* ~f~) + τ~RF~\] for the filter block with gradient duration *δ* ~f~, and TE = 2\[*δ*(*g,b*) + τ~RF~ + (HF -- 0.5) *τ* ~EPI~\] for the detection block with gradient duration *δ*. Here, τ~RF~ is the duration of the inversion pulse (8 ms) and HF is the half scan factor (0.7). The repetition times were calculated as TR = *t* ~m~ *n* ~slice~ + TR~0~, where TR~0~ = *n* ~slice~(TE~f~ + TE) ≥ 33*g*. The last inequality modeled duty‐cycle restriction and had to be incorporated to execute the protocol with our software implementation. Improving the implementation may make it less restrictive.

The objective function was minimized using the stochastic self organizing migrating algorithm (SOMA, <http://www.ft.utb.cz/people/zelinka/soma/>). SOMA randomizes a population of guess vectors of the optimization parameters, based on their allowed intervals. A number of "migrations" are performed, in which the best guess (according to the objective function) is identified as the "leader," toward which the rest of the population performs randomized steps (migrations). SOMA was executed six times with default settings, but with 100 migrations for a population size of 18, after which the best protocol was chosen.

To assess the optimization yield, we considered the ratio of the CRLB‐based CV estimate of the optimized protocol versus that of the previously presented protocol [21](#mrm26195-bib-0021){ref-type="ref"}. Seeing that the protocols had different T^aq^, the ratio was corrected with ( $T_{\text{new}}^{\text{aq}}$/ $T_{\text{old}}^{\text{aq}}$)^1/2^, using SNR ∝ (T^aq^)^1/2^. The obtained metric corresponds to the change in CV assuming equal T^aq^.

Methodological Validations {#mrm26195-sec-0013}
--------------------------

We validated the CRLB‐based CV estimate by comparing it with the CV estimated in a simulation procedure. A synthetic data set of 10^4^ samples was created by adding Rice‐distributed noise to the signal (Eq. [(4)](#mrm26195-disp-0004){ref-type="disp-formula"}) using a fixed SNR. The AXR standard deviation was then estimated from the set of AXR values obtained by fitting the model to each of the samples. The comparison was performed for AXR ground‐truth values between 0.1 and 5.0 s^−1^, whereas the other model parameters were fixed (ADC = 0.7 μm^2^/ms and σ = 0.3).

It is well known that ADC is optimally estimated using only two *b*‐values [39](#mrm26195-bib-0039){ref-type="ref"}. Here, this was assumed also for *t* ~m~ in AXR estimation, as it can be seen as a series of exponential fits using first *b* and then *t* ~m~. We tested the assumption by studying how the objective function was affected when protocols were modified to include a third mixing time ( $t_{m}^{\text{mid}}$).

To assess the importance of the gradients for the optimal protocol, we also executed the full optimization procedure with an upper limit of *g* of 40 mT/m. Furthermore, to examine the sensitivity of the optimized protocol to changes in parameter values, we studied how the objective function (Eq. [(7)](#mrm26195-disp-0007){ref-type="disp-formula"}) changed over the optimization ranges of *b* ~f~ and *b* ^max^ (Table [1](#mrm26195-tbl-0001){ref-type="table-wrap"}).

FEXI Acquisition and Postprocessing {#mrm26195-sec-0014}
-----------------------------------

FEXI data were acquired on a Philips Achieva 3 Tesla (T) system (Amsterdam, Netherlands), equipped with 80 mT/m gradients with a maximum slew rate of 100 mT/m/ms on axis and an eight‐channel head coil, using the sequence implementation of Nilsson et al [21](#mrm26195-bib-0021){ref-type="ref"} and the optimized protocol. Seven contiguous axial slices were obtained at the spatial resolution of 3 × 3 × 5 mm^3^, with TE~f~/TE/TR = 39/66/2000 ms/ms/ms, yielding T^aq^ = 13 min. The timing parameters of the filter and detection blocks were δ~f~/δ = 11/10 ms/ms and Δ~f~/Δ = 31/31 ms/ms.

Data were obtained from 18 healthy volunteers (9 male, 9 female, age 30 ± 7 years, mean ± standard deviation), a group of 6 meningioma patients (all female, age 59 ± 5 years), and a group of 5 astrocytoma patients (4 male, 1 female, age 45 ± 11 years). All tumor patients were scanned before surgical excision. In the volunteers, FEXI data were obtained twice in the same session to assess the test‐retest variability. Additionally, we acquired whole‐brain DTI data, fluid‐attenuated inversion recovery (FLAIR), and T~1~‐weighted (T1W) images. The FLAIR and T1W images were coregistered to the FEXI data using the Elastix software package [40](#mrm26195-bib-0040){ref-type="ref"}, [41](#mrm26195-bib-0041){ref-type="ref"}. The study was approved by the Regional Ethical Review Board at Lund University, and all subjects gave written informed consent.

The FEXI image volumes were corrected for motion and eddy currents with Elastix, using an extrapolation‐based approach [42](#mrm26195-bib-0042){ref-type="ref"}. To ensure a rotationally invariant metric, the data were averaged arithmetically across the diffusion‐encoding directions before model fitting. Previous papers on exchange imaging have used either geometric averaging [21](#mrm26195-bib-0021){ref-type="ref"}, [43](#mrm26195-bib-0043){ref-type="ref"}, which is more sensitive to noise than the arithmetic average, or a tensor‐based approach [22](#mrm26195-bib-0022){ref-type="ref"}, which demands higher SNR than available at our clinical scanner. For region of interest (ROI) based analysis, the signal vectors were also averaged across the ROI voxels. Maps of the FEXI model parameters were obtained by fitting Eq. [(4)](#mrm26195-disp-0004){ref-type="disp-formula"}, and keeping *S* ~0~ as a free parameter for each *t* ~m~.

Test‐Retest Study {#mrm26195-sec-0015}
-----------------

In the analysis, the test‐retest data were obtained from six ROIs defined manually on directionally encoded color (DEC) maps. The ROIs are illustrated for one volunteer in Figure [2](#mrm26195-fig-0002){ref-type="fig"}, and were positioned in the anterior corona radiata (ACR), the anterior limb of the internal capsule (ALIC), the genu and splenium of the corpus callosum (CC), the cerebrospinal tract (CST), the lentiform nucleus (LN), and the thalamus (TH). Regional specificity took precedence over ROI volume. ADC, σ, and AXR were estimated in the ROIs and described with respect to mean and standard deviation, calculated from all 2 × 18 measurements. Additionally, for the AXR, the CV was calculated and the paired test‐retest data were used to calculate *RV* ~M~. Finally, for each ROI and multiple AXR effect sizes, the estimated *V* of AXR estimates were used to calculate the group sizes required to achieve a statistical power of 0.8 at α = 0.05. In this calculation, we assumed groups with equal *n* and *V*.

![The six ROIs used in the test‐retest study, with data from one volunteer. ROIs were defined manually on DEC maps: the anterior corona radiata (ACR, dark red), the anterior limb of the internal capsule (ALIC, dark green), the genu and splenium of the corpus callosum (CC, dark blue), the cerebrospinal tract (CST, light red), the lentiform nucleus (LN, light green), and the thalamus (TH, light blue).](MRM-77-1104-g002){#mrm26195-fig-0002}

Intracranial Tumor Study {#mrm26195-sec-0016}
------------------------

The solid part of each tumor was defined manually on the ADC map, guided by the coregistered T1W and FLAIR images. ROI volumes were between 57 and 179 voxels for meningiomas and 29 and 150 voxels for astrocytomas. ADC, σ, and AXR were estimated in each ROI and compared between the tumor groups using the Student\'s *t*‐test and the Mann‐Whitney U‐test (both Bonferroni corrected for the three comparisons).

After surgical excision, the specimens were paraffin‐embedded and fixed in 4% buffered formaldehyde solution. Sections of 4 μm were stained with hematoxylin‐eosin for visualization of tissue structure and cell morphology. The tumors were assessed neuropathologically, and microphotos were obtained from the specimens using an Olympus BX50 (Tokyo, Japan).

RESULTS {#mrm26195-sec-0017}
=======

Protocol Optimization {#mrm26195-sec-0018}
---------------------

The optimized protocol is presented in Table [1](#mrm26195-tbl-0001){ref-type="table-wrap"}. Compared with the protocol used by Nilsson et al [21](#mrm26195-bib-0021){ref-type="ref"}, the CV of the AXR was reduced by approximately 40%, assuming equal T^aq^. Noteworthy changes include the use of only two different *t* ~m~ (16 and 442 ms) rather than including a range of intermediate values, and using a higher *b* ^max^ (increased from 900 to 1300 s/mm^2^) [21](#mrm26195-bib-0021){ref-type="ref"}. The optimized protocol featured the upper limit for *b* ^max^ and for the maximal gradient amplitude *g* (80 mT/m).

Methodological Validations {#mrm26195-sec-0019}
--------------------------

Figure [3](#mrm26195-fig-0003){ref-type="fig"}a compares the CRLB‐based CV estimate (black) to the simulated CV (red). The CRLB‐based estimate yielded a negligible overestimation for AXR \< 2 s^−1^, and a moderate underestimation for AXR between 3--5 s^−1^, but overall the two metrics showed good agreement.

![(a) Validation of the CRLB‐based CV estimate (black) by comparison with the CV estimated in a simulation experiment (red). The values for ADC and σ were fixed (ADC = 0.7 μm^2^/ms and σ = 0.3). The CRLB‐based estimate yielded a moderate underestimation for AXR values between 3 and 5 s^−1^, but was generally accurate. (b) Validation of the assumption that using only two different *t* ~m~ is optimal for AXR estimation. The curves show how the CV of the AXR was affected when the optimized protocol was altered to obtain different percentages of samples at a third mixing time ( $t_{m}^{\text{mid}}$). For each value of $t_{m}^{\text{mid}}$, the CV increased monotonically with increased time spent sampling it. (c) Investigation of the performance sensitivity of the optimized protocol to changes in *b* ~f~ and *b* ^max^. The objective function (Eq. [(7)](#mrm26195-disp-0007){ref-type="disp-formula"}) was plotted over the ranges used in the optimization. The labeled contours show the percentage increase in CV from the optimized protocol (star).](MRM-77-1104-g003){#mrm26195-fig-0003}

The rationale for using only two different mixing times is shown in Figure [3](#mrm26195-fig-0003){ref-type="fig"}b, where the CV of the AXR of a modified protocol is plotted against the percentage of samples obtained with $t_{m}^{\text{mid}}$. For all investigated protocols, we observed that adding samples at any $t_{m}^{\text{mid}}$ leads to an increased CV.

In the optimization executed with a reduced upper limit of *g* (40 mT/m), the obtained protocol still featured the maximal allowed value of *g*, whereas $t_{m}^{\max}$ settled at a slightly lower value of 378 ms, and *b* ~f~ and *b* ^max^ were reduced to 660 and 1100 s/mm^2^, respectively. Also, TE~f~ and TE increased by 30 and 20%, respectively, and the CV almost doubled as a consequence.

Figure [3](#mrm26195-fig-0003){ref-type="fig"}c shows the change of the objective function (Eq. [(7)](#mrm26195-disp-0007){ref-type="disp-formula"}) over the optimization ranges of *b* ~f~ and *b* ^max^. The labeled contours show the percentage increase compared with the optimized protocol (marked by a star). CV changes were small (\<10%) for *b* ~f~ ∊ \[600, 950\] s/mm^2^ and *b* ^max^ ∊ \[1000, 1300\] s/mm^2^.

Test‐Retest Study {#mrm26195-sec-0020}
-----------------

Figure [4](#mrm26195-fig-0004){ref-type="fig"} shows maps of ADC, σ, and AXR from one of the volunteers. The AXR map exhibits a heterogeneous contrast in the brain that was seen in many of the volunteers, including the previously observed distinctively high values in the frontal white matter [21](#mrm26195-bib-0021){ref-type="ref"}. The test‐retest results for the parameters are presented in Table [2](#mrm26195-tbl-0002){ref-type="table-wrap"}, with ROI means and standard deviations, and values of CV and *RV* ~M~ for the AXR. The mean AXR values varied substantially across the ROIs, being high in the ACR, intermediate in the TH, the LN and the ALIC, and low in the CST and the CC. The AXR estimates exhibited relatively high values of the CV, with a median of 41%. Values of *RV* ~M~ were also high, meaning that most of the variance was induced by the measurement rather than from the population. The observed test‐retest repeatability of the AXR is illustrated in Figure [5](#mrm26195-fig-0005){ref-type="fig"} by a scatter plot (left) and a Bland‐Altman plot (right), with test‐retest data pairs color‐coded by ROI. The scatter plot shows AXR~test~ versus AXR~retest~, which were clustered by ROI and correlated well. In the Bland‐Altman plot, the test‐retest AXR difference is plotted against the test‐retest AXR mean. A significant test‐retest bias was observed in the ACR (12%, Bonferroni corrected for the six comparisons).

![Maps of the FEXI model parameters ADC, σ, and AXR from one volunteer, all gamma corrected with γ = 0.7. The σ parameter is the filter efficiency, which shows the degree to which ADC is reduced by the action of the filter block. The heterogeneous contrast in the brain of the AXR map exemplifies the maps seen in the volunteers, including the distinctively high values in the frontal white matter observed previously [21](#mrm26195-bib-0021){ref-type="ref"}.](MRM-77-1104-g004){#mrm26195-fig-0004}

![Illustration of the test‐retest repeatability of the AXR in the 18 healthy volunteers, by a scatter plot (left) and a Bland‐Altman plot (right). Test and retest AXR are denoted as AXR~t1~ and AXR~t2~, respectively; AXR~mean~ is their mean; and ΔAXR is AXR~t2~ − AXR~t1~. In the scatter plot, the line corresponds to zero test‐retest difference, and in the Bland‐Altman plot, the lines denote the mean (solid) and limits (dashed) of a 95% confidence interval for AXR test‐retest differences, taken across all ROIs and all subjects. The dots are test‐retest data pairs, color‐coded by ROI. The plots (approximately) illustrate the measurement variance by distances of points to the middle lines, intersubject variance by spread of same‐colored points, and across‐ROI variance by spread of clusters of different‐colored points. The points show good correlation and are clustered by ROI. A significant test‐retest bias was observed in the ACR (12%).](MRM-77-1104-g005){#mrm26195-fig-0005}

###### 

FEXI Test‐Retest Results In the 18 Healthy Volunteers[a](#mrm26195-note-0003){ref-type="fn"}

  ROI    ADC (μm^2^/ms)   σ           AXR (s^−1^)   CV~AXR~ (%)   (*RV* ~M~)~AXR~ (%)
  ------ ---------------- ----------- ------------- ------------- ---------------------
  ACR    0.7 ± 0.1        0.3 ± 0.1   1.8 ± 0.3     14            60
  ALIC   0.6 ± 0.1        0.3 ± 0.1   0.9 ± 0.3     35            70
  CC     0.7 ± 0.1        0.4 ± 0.1   0.3 ± 0.2     78            68
  CST    0.6 ± 0.1        0.3 ± 0.1   0.4 ± 0.1     32            100
  LN     0.7 ± 0.1        0.1 ± 0.1   1.2 ± 0.6     46            76
  TH     0.8 ± 0.1        0.2 ± 0.1   0.8 ± 0.4     47            78

Shown for the 2 × 18 measurements are the ADC, sigma, and AXR (mean ± standard deviation) along with the CV and the RVM for the AXR. The AXR values were heterogeneous across the ROIs, and particularly high in the ACR.

**Note**: ACR, anterior corona radiata; ALIC, anterior limb of the internal capsule; CC, genu and splenium of the corpus callosum; CST, cerebrospinal tract; LN, lenticular nucleus; TH, thalamus.

Analysis of statistical power indicated that, in a ROI analysis, group mean differences in the AXR of 0.3--0.5 s^−1^ can be inferred using groups of 5 to 10 subjects per group. This was true for all investigated brain regions barring the LN, which showed higher variance.

Intracranial Tumor Study {#mrm26195-sec-0021}
------------------------

Figure [6](#mrm26195-fig-0006){ref-type="fig"} shows FEXI parameter maps for each subject in the meningioma and the astrocytoma groups, together with coregistered T1W and FLAIR images. The meningiomas exhibited homogenously low AXR values, with the clear exception of case (f), which we considered to be an outlier. This case exhibited similar values of ADC and σ compared with the other meningiomas, although parts of it exhibited a darker FLAIR contrast, a feature that was also observed in parts of cases (a) and (c). This last finding may be explained by a *T* ~2~ reduction caused by a more fibrous content. In the AXR maps of the astrocytomas, the AXR was elevated compared with the normal appearing brain, and the elevation seemed correlated with the tumor outline in the T1W and FLAIR images. The FEXI parameters obtained in solid parts of the tumors are given in Table [3](#mrm26195-tbl-0003){ref-type="table-wrap"}. The meningiomas exhibited low AXR values (0.6 ± 0.1 s^−1^, mean ± standard deviation), excluding the outlier for which AXR = 1.7 s^−1^. The AXR values of astrocytomas (1.0 ± 0.3 s^−1^) were significantly higher according to both the *t*‐test and the U‐test (Δμ~AXR~ = 0.4 s^−1^, CI~95~ = \[0.2--0.6\] s^−1^, *P* \< 0.05). The astrocytomas also exhibited significantly higher ADC values (1.2 ± 0.2 µm^2^/ms) compared with the meningiomas (0.8 ± 0.1 µm^2^/ms).

![Overview of the FEXI parameter maps in the six meningioma and five astrocytoma patients, together with coregistered T1W and FLAIR images, all gamma‐corrected with γ = 0.7. The AXR values of the meningiomas were homogenously low (mean ± standard deviation, 0.6 ± 0.1 s^−1^), excluding the meningioma outlier case (f) in which AXR = 1.7 s^−1^. The astrocytomas exhibited significantly higher AXR values (1.0 ± 0.3 s^−1^) and ADC values (1.2 ± 0.2 versus 0.8 ± 0.1 µm^2^/ms). The outlier exhibited similar ADC and σ to the other meningiomas, although parts of it, and parts of cases (a) and (c), exhibited a darker FLAIR contrast, which could be caused by a more fibrous content.](MRM-77-1104-g006){#mrm26195-fig-0006}

###### 

FEXI Parameter Values In Meningiomas and Astrocytomas[a](#mrm26195-note-0005){ref-type="fn"}

  Group          *n*   ADC (μm^2^/ms)                                                                              σ           AXR (s^−1^)                                        CV~AXR~ (%)
  -------------- ----- ------------------------------------------------------------------------------------------- ----------- -------------------------------------------------- -------------
  meningioma     6     0.8 ± 0.1[b](#mrm26195-note-0006){ref-type="fn"}                                            0.2 ± 0.1   0.8 ± 0.4                                          58
  meningioma\*   5     0.8 ± 0.1[c](#mrm26195-note-0007){ref-type="fn"}                                            0.2 ± 0.1   0.6 ± 0.1[d](#mrm26195-note-0008){ref-type="fn"}   20
  astrocytoma    5     1.2 ± 0.2[b](#mrm26195-note-0006){ref-type="fn"}, [c](#mrm26195-note-0007){ref-type="fn"}   0.2 ± 0.1   1.0 ± 0.3[d](#mrm26195-note-0008){ref-type="fn"}   26

FEXI parameter values are presented, with group means and standard deviation, for the meningioma group (six patients, grade I) and the astrocytoma group (five patients, grade II--IV). The meningioma\* group is the meningioma group with one outlier excluded.

astrocytoma versus meningioma, *P* \< 0.05, CI~95%~ \[0.3 0.6\].

astrocytoma versus meningioma\*, *P* \< 0.05, CI~95%~ \[0.2 0.7\].

astrocytoma versus meningioma\*, *P* \< 0.05, CI~95%~ \[0.2 0.6\].

Tumor specimen microphotos are showed in Figure [7](#mrm26195-fig-0007){ref-type="fig"}. In the neuropathological assessment, the meningioma specimens were classified as grade I [44](#mrm26195-bib-0044){ref-type="ref"} with varying histopathological types, including fibroblastic, syncytial, and transitional. The outlier meningioma, case (f), was of a transitional type and exhibited microscopic signs of increased growth potential, bringing it close to grade II (atypical). The astrocytoma specimens were classified as grade II--IV [44](#mrm26195-bib-0044){ref-type="ref"}, and were heterogeneous with respect to cell density and signs of increased malignancy. In general, the meningiomas exhibited a dense growth pattern with high tissue cohesion and structures such as sheets and bundles, and often contained elongated cells. In contrast, the astrocytomas exhibited a looser, more homogeneous tissue structure, and showed no obvious anisotropy on the cellular scale.

![Microphotos of specimens of the surgically excised tumors. The meningiomas were grade I and had different histopathological types: fibroblastic in cases (a), (b), (d), and (e), fibroblastic/syncytial in case (c), and transitional in case (f). The outlier meningioma case (f) was close to grade II, as it exhibited microscopic signs of increased growth potential, such as slight nuclear atypia and pleomorphism, and incipient necroses. The astrocytomas were of different grades: IV in case (a) and (b), II and III in case (c) and (d), and II in case (e). They exhibited different degrees of cell density and signs of increased malignancy, such as high mitotic activity, vascular proliferation, and necrosis. The main histopathological difference between the tumor types was a denser and more cohesive tissue structure of meningiomas and the presence of elongated cells and structures such as sheets or bundles.](MRM-77-1104-g007){#mrm26195-fig-0007}

DISCUSSION {#mrm26195-sec-0022}
==========

FEXI employs DDE for measuring the AXR, a quantity that cannot be estimated using ordinary DWI methods, such as DTI or DKI. In this work, the FEXI protocol was optimized for minimal AXR variance in the normal brain.

The optimized protocol, presented in Table [1](#mrm26195-tbl-0001){ref-type="table-wrap"} and also in [45](#mrm26195-bib-0045){ref-type="ref"}, reduced the CV of the AXR by approximately 40%, compared with the previously presented protocol [21](#mrm26195-bib-0021){ref-type="ref"}, corresponding to a reduction of more than 60% in T^aq^. Further reduction of variance and/or T^aq^ can be achieved by technological improvements. The most important limiting hardware factor in the optimization was the maximal gradient amplitude (*g*), which attained its upper limit (80 mT/m) despite accounting for a duty‐cycle limitation by increasing TR linearly with *g*. Minimizing TE by using stronger gradients thus increases the SNR more effectively than minimizing TR to obtain more samples, at least for an assumed *T* ~2~ of 50 ms. Systems with stronger gradients are available at some sites, eg, 300 mT/m at the human connectome scanner [46](#mrm26195-bib-0046){ref-type="ref"}.

For performing FEXI on systems with different hardware configurations, we recommend using the protocol in Table [1](#mrm26195-tbl-0001){ref-type="table-wrap"} with small modifications. A change in the SNR, eg, from using a coil with more channels (which was eight in this study), should not affect the optimal protocol, provided that the noise distribution remains approximately Gaussian (SNR \> 2). A change in the available sampling time, such as an increased T^aq^ or a reduced *n* ~slice~, can be accommodated by adding extra samples while preserving the ratios *\#b* ^min^/\#*b* ^max^ and \# $t_{m}^{\text{min}}$/\# $t_{m}^{\text{max}\rbrack}$. A change in *g*, however, would affect TE~f~ and TE, and possibly the optima for *b* ~f~ and *b* ^max^. We make two points concerning this matter. First, we do not recommend breaking the upper *b*‐value limit (1300 s/mm^2^) due to the bias it may cause in the FEXI model. Second, the optimization performed with a halved upper limit of *g* (40 mT/m) reduced the optimal values for *b* ~f~ and *b* ^max^ by approximately 200 s/mm^2^. As illustrated in Figure [3](#mrm26195-fig-0003){ref-type="fig"}c, *b*‐value reductions of this magnitude, alone, have only a small effect on the CV. Therefore, we conclude that most clinical systems should get near‐optimal performance using slightly reduced values for *b* ~f~ and *b* ^max^.

When performing FEXI on other organs than the brain, new optimizations, including whether to use more than two mixing times, are necessary to account for differences in tissue priors and relaxation properties. Preliminary results using a FEXI protocol optimized for the breast has already been presented [24](#mrm26195-bib-0024){ref-type="ref"}. Generally, faster exchange demands shorter mixing times, and vice versa, due to the exponential coupling of AXR and *t* ~m~ (Eq. [(3)](#mrm26195-disp-0003){ref-type="disp-formula"}). This is illustrated by the valley shape of the CV in Figure [3](#mrm26195-fig-0003){ref-type="fig"}a. The valley can be seen as a "measurement window," in which the timescales of the system (the exchange time, τ~i~) and the measurement (*t* ~m~) are well matched. Choosing the proper *t* ~m~ moves the window to the AXR range of interest.

In the test‐retest study, the AXR was highest in the ACR and lowest in the CC, which also exhibited the highest CV values. In periventricular structures such as the CC, the AXR could be negatively biased by partial volume effects with cerebrospinal fluid (CSF) [21](#mrm26195-bib-0021){ref-type="ref"}. Over all regions, the CV values of the AXR ranged between 14 and 78%. This is relatively large compared with other high *b*‐value techniques, such as diffusion kurtosis imaging (DKI), in which the CV is 4--8% for mean diffusivity and fractional anisotropy, and 3--15% for mean kurtosis and radial kurtosis [28](#mrm26195-bib-0028){ref-type="ref"}. The values of *RV* ~M~, however, suggested that more than two thirds of the variance in AXR was caused by measurement noise, which is more than what has been estimated for the DKI parameters (4--54%) [28](#mrm26195-bib-0028){ref-type="ref"}. Variance in the AXR can thus be effectively addressed by technological advancements and system upgrades, if prolonged scan times are not an option. Nevertheless, according to the analysis of statistical power, regional mean differences in the AXR of 0.3--0.5 s^−1^, thus comparable to the observed increase in astrocytomas compared with meningiomas (0.4 s^−1^), can already be inferred using rather small groups of 5 to 10 subjects each. An AXR effect size well beyond this (1--2 s^−1^) was reported by Schilling et al from preliminary results of urea transporter gene expression [23](#mrm26195-bib-0023){ref-type="ref"}.

In the tumor study, there was a significant difference in AXR between astrocytomas (1.0 ± 0.3 s^−1^) and meningiomas (0.6 ± 0.1 s^−1^), excluding a meningioma outlier. The astrocytomas also exhibited a significantly higher ADC (1.2 ± 0.2 versus 0.8 ± 0.1 µm^2^/ms), but there are reasons to suspect that these findings are independent. First, the ADC is often related to tumor cell density [47](#mrm26195-bib-0047){ref-type="ref"}, and a higher ADC in the histopathologically less dense astrocytomas is therefore unsurprising. Second, the AXR has been shown to be uncorrelated with ADC in the human brain in vivo [21](#mrm26195-bib-0021){ref-type="ref"}. Finally, although the ADC is sensitive to cell permeability, the effect is almost negligible until the permeability becomes very high [48](#mrm26195-bib-0048){ref-type="ref"}. Interestingly, ADC shows promise as a fast marker of treatment response [49](#mrm26195-bib-0049){ref-type="ref"} due to its sensitivity to treatment‐induced tumor cell‐kill [50](#mrm26195-bib-0050){ref-type="ref"}. If the cell‐kill is preceded by permeability changes, the AXR may be an even faster and more sensitive marker.

The main histopathological difference between the tumor types was a denser, more cohesive, and structured tissue of meningiomas compared with astrocytomas. We hypothesize that higher tissue cohesion might reduce the effective surface‐to‐volume ratio of the intracellular compartment and contribute to a lower intra‐extracellular exchange rate. The hemorrhage seen in the outlier meningioma was considered by the neuropathologist to be of surgical origin, and not present at the time of the MRI scan. However, it might have been inherent, signaling an increased vascular leakage of more proliferative tumors. Hemorrhage may otherwise cause elevated levels of iron in the tissue, resulting in stronger background gradients that may potentially affect the AXR quantification. It is interesting that the meningioma outlier, which exhibited an almost tripled AXR compared with the others, was close to being grade II, and was suspected possibly aggressive and invasive by the surgeon. Expression of AQP is considered conducive to cell migration [51](#mrm26195-bib-0051){ref-type="ref"}, and its upregulation has been demonstrated in aggressive tumors, including high grade astrocytomas [13](#mrm26195-bib-0013){ref-type="ref"}, [14](#mrm26195-bib-0014){ref-type="ref"}, [15](#mrm26195-bib-0015){ref-type="ref"}. In this study, the tumor with the highest grade (IV) also showed the highest AXR (1.4 s^−1^) among the astrocytomas. We hypothesize that there might be a connection between water exchange and tumor grade. This should be tested in future studies using larger sample sizes of multiple tumor types with different grades.

We identified six main limitations of this study. First, the CRLB is a lower bound for parameter variance only if the signal model is without bias, which is a strong assumption. However, the CRLB showed a good agreement with the simulated variance (Fig. [4](#mrm26195-fig-0004){ref-type="fig"}). Also, we did not address bias in the study, but focused on optimizing the potential for observing population‐wise differences in the AXR. Sources of bias should be addressed in future studies. Second, the CRLB cannot account for variance caused by artifacts rather than thermal noise. We observed that using an extrapolation‐based motion correction [42](#mrm26195-bib-0042){ref-type="ref"} reduced the variance in AXR compared with the preliminary results published previously [52](#mrm26195-bib-0052){ref-type="ref"}, which were based on the same test‐retest data but used a conventional motion correction. Third, the optimization did not account for T2\* blurring during *τ* ~EPI~. Fourth, the field of view (FOV) in the slice direction was only 35 mm in our implementation. This limitation may be resolved by multiband excitation [53](#mrm26195-bib-0053){ref-type="ref"}. With a multiband factor of three, the FOV would be enhanced to 105 mm, which is almost full brain coverage. Fifth, we observed an unexpected test‐retest bias in the ACR, which we speculate was induced by subjects turning their heads toward the end of the session. Because subjects were in a supine position, the largest rotation would happen frontally in the brain. Sixth, predictions on group sizes must be interpreted with care for comparisons involving a pathological group, as the present analysis was based on variance estimates in the normal brain.

CONCLUSIONS {#mrm26195-sec-0023}
===========

We present an optimized 13‐min clinical FEXI protocol that reduced the CV of the AXR by approximately 40%, and thus T^aq^ by more than 60%. In the test‐retest study, the observed AXR variance was primarily caused by measurement noise, rather than intersubject differences. This promises additional CV reductions from technological upgrades, such as better coils and stronger gradient systems. Limited coverage can be addressed by, eg, multiband excitation. Already, with this protocol, group‐wise differences of a magnitude demonstrated between meningiomas and astrocytomas would be inferable between groups of 5 to 10 subjects. We conclude that optimized FEXI has the ability to infer relevant differences in the AXR between two populations for small group sizes.
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